News

Impilo & Pelago Bioscience Partnership!

Impilo invests in Pelago Bioscience AB and enters a partnership to accelerate Pelago’s growth. Founded in 2013, Pelago is a fast-growing drug discovery focused contract research organisation offering services based on the patented CEllular Thermal Shift Assay (CETSA®) technology…

Read more

New CETSA® Publication – A Shift in Thinking

We are thrilled to share our latest publication in the journal “ACS Medicinal Chemistry Letters” titled – A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery.   In this study, we highlighted recently published applications of CETSA® and how…

Read more

CETSA® Conference, september 28

Pelago Bioscience is bringing together the CETSA® community to inspire, learn and unleash drug discovery. As Pelago is expanding its portfolio of services and technologies, we remain committed to empowering our partners in accelerating drug discovery. As a part…

Read more

Webinar DTR

The Cellular Thermal Shift Assay (CETSA®) is an easy and proven method to demonstrate ligand-protein interactions in living cells and can be used without the need of any modifications to the ligand or protein. Quantification methods like PerkinElmer’s no-wash immunoassays…

Read more

Press Release – New Facility

Pelago Bioscience AB expands to new facility After several years of continued growth in our current facilities Pelago Bioscience now really expands. The new building is located at Campus Solna, a rapidly developing Life Science cluster located in central…

Read more

April 7 Webinar

Confirmation of target engagement in relevant physiological environment ensures successful drug discovery and the right project prioritization. By applying CETSA®, you can make better and more informed decisions at earlier stages in your drug discovery projects. Welcome to learn from…

Read more

Gasell prize to Pelago-again

Time to celebrate – For the third year in a row, Pelago has been awarded the prestigious DI Gasell prize by the Swedish daily business newspaper Dagens Industri. This prize recognizes the fastest growing Swedish companies, with less than 1…

Read more

New interesting CETSA® paper in Nature protocols

Don’t miss this new interesting CETSA® paper published in Nature Protocols. https://www.nature.com/articles/s41596-020-0310-z Are you sure? Is you target compound really theraputic? Speak to our experts Learn how CETSA® can enable your project by talking to one of our Drug Discovery…

Read more